Gaisinskaya Polina, VanHelmond Taylor A, Reano Katherine
Internal Medicine, Florida Atlantic University, Florida, USA.
Cureus. 2022 May 23;14(5):e25234. doi: 10.7759/cureus.25234. eCollection 2022 May.
Coronavirus disease 2019 (COVID-19) was a novel virus that originated in China in November 2019 and is most known for its respiratory compromise; however, many patients have experienced vascular thrombosis as sequelae of COVID-19. It is thought that the virus causes endothelial cell damage and increased platelet and leukocyte adhesion, causing a hypercoagulable state. While the most common presentation of hypercoagulability associated with COVID-19 is venous thrombosis, there are reports of patients who present with acute limb ischemia. We present a case of acute leg ischemia in an otherwise asymptomatic patient with no atherosclerotic risk factors.
2019冠状病毒病（COVID-19）是一种于2019年11月在中国出现的新型病毒，以导致呼吸功能受损最为人所知；然而，许多患者出现了血管血栓形成这一COVID-19后遗症。据认为，该病毒会导致内皮细胞损伤以及血小板和白细胞黏附增加，从而引发高凝状态。虽然与COVID-19相关的高凝状态最常见的表现是静脉血栓形成，但也有患者出现急性肢体缺血的报道。我们报告一例无动脉粥样硬化风险因素、原本无症状的患者发生急性腿部缺血的病例。
